Literature DB >> 25368022

ISG15 is a critical microenvironmental factor for pancreatic cancer stem cells.

Bruno Sainz1, Beatriz Martín2, Marianthi Tatari3, Christopher Heeschen4, Susana Guerra5.   

Abstract

Cancer stem cells (CSC) are thought to play a major role in the development and metastatic progression of pancreatic ductal adenocarcinoma (PDAC), one of the deadliest solid tumors. Likewise, the tumor microenvironment contributes critical support in this setting, including from tumor stromal cells and tumor-associated macrophages (TAM) that contribute structural and paracrine-mediated supports, respectively. Here, we show that TAMs secrete the IFN-stimulated factor ISG15, which enhances CSC phenotypes in PDAC in vitro and in vivo. ISG15 was preferentially and highly expressed by TAM present in primary PDAC tumors resected from patients. ISG15 was secreted by macrophages in response to secretion of IFNβ by CSC, thereby reinforcing CSC self-renewal, invasive capacity, and tumorigenic potential. Overall, our work demonstrates that ISG15 is a previously unrecognized support factor for CSC in the PDAC microenvironment with a key role in pathogenesis and progression. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25368022     DOI: 10.1158/0008-5472.CAN-14-1354

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  A new PDAC mouse model originated from iPSCs-converted pancreatic cancer stem cells (CSCcm).

Authors:  Anna Sanchez Calle; Neha Nair; Aung KoKo Oo; Marta Prieto-Vila; Megumi Koga; Apriliana Cahya Khayrani; Maram Hussein; Laura Hurley; Arun Vaidyanath; Akimasa Seno; Yoshiaki Iwasaki; Malu Calle; Tomonari Kasai; Masaharu Seno
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  The Effect of SH2B1 Variants on Expression of Leptin- and Insulin-Induced Pathways in Murine Hypothalamus.

Authors:  Johanna Giuranna; Anna-Lena Volckmar; Anna Heinen; Triinu Peters; Börge Schmidt; Anne Spieker; Helena Straub; Harald Grallert; Timo D Müller; Jochen Antel; Ute Haußmann; Hans Klafki; Liangyou Rui; Johannes Hebebrand; Anke Hinney
Journal:  Obes Facts       Date:  2018-04-10       Impact factor: 3.942

3.  Deleting key autophagy elongation proteins induces acquirement of tumor-associated phenotypes via ISG15.

Authors:  EunBin Kong; Hag Dong Kim; Joon Kim
Journal:  Cell Death Differ       Date:  2020-03-03       Impact factor: 15.828

4.  Proteomic and bioinformatic profiling of neutrophils in CLL reveals functional defects that predispose to bacterial infections.

Authors:  Nirojah Subramaniam; Jenny Bottek; Stephanie Thiebes; Kristina Zec; Matthias Kudla; Camille Soun; Elena de Dios Panal; Julia K Lill; Aaron Pfennig; Ralf Herrmann; Kirsten Bruderek; Sven Rahmann; Sven Brandau; Patricia Johansson; Hans Christian Reinhardt; Jan Dürig; Martina Seiffert; Thilo Bracht; Barbara Sitek; Daniel Robert Engel
Journal:  Blood Adv       Date:  2021-03-09

5.  Chemoresistance in pancreatic cancer: Emerging concepts.

Authors:  Manu Gnanamony; Christopher S Gondi
Journal:  Oncol Lett       Date:  2017-02-24       Impact factor: 2.967

6.  Loss of TRIM29 suppresses cancer stem cell-like characteristics of PDACs via accelerating ISG15 degradation.

Authors:  Jia Sun; Jing Yan; Huai-Yu Qiao; Fu-Ying Zhao; Chao Li; Jing-Yi Jiang; Bao-Qin Liu; Xiao-Na Meng; Hua-Qin Wang
Journal:  Oncogene       Date:  2019-09-09       Impact factor: 9.867

Review 7.  Circulating cancer stem cells: the importance to select.

Authors:  Ming-Hsin Yang; Ahmet Imrali; Christopher Heeschen
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

8.  Prognostic value of NUSAP1 in progression and expansion of glioblastoma multiforme.

Authors:  Zhiyuan Qian; Yuping Li; Jiawei Ma; Yanping Xue; Yujun Xi; Lei Hong; Xiaoxiao Dai; Yongsheng Zhang; Xiaoyan Ji; Yanming Chen; Minfeng Sheng; Yujing Sheng; Lin Yang; Jiachi Liu; Xingliang Dai; Jia Shi; Tao Xie; Jun Dong
Journal:  J Neurooncol       Date:  2018-07-11       Impact factor: 4.130

Review 9.  Myeloid immunosuppression and immune checkpoints in the tumor microenvironment.

Authors:  Kyohei Nakamura; Mark J Smyth
Journal:  Cell Mol Immunol       Date:  2019-10-14       Impact factor: 11.530

10.  Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.

Authors:  Fang Lyu; Yunxue Li; Zhecheng Yan; Qingliu He; Lulin Cheng; Pu Zhang; Bing Liu; Chunyu Liu; Yarong Song; Yifei Xing
Journal:  J Transl Med       Date:  2022-05-10       Impact factor: 8.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.